‌

US Patent 8513390 Modified antibody compositions, methods of making and using thereof

Patent 8513390 was granted and assigned to CytomX Therapeutics on August, 2013 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

CytomX Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8513390

Date of Patent

August 20, 2013

Patent Application Number

13455924

Date Filed

April 25, 2012

Patent Citations Received

‌

US Patent 12128102 Constrained conditionally activated binding proteins

‌

US Patent 12077783 AAV-mediated delivery of antibodies to the inner ear

‌

US Patent 12091442 Activatable cytokine constructs and related compositions and methods

‌

US Patent 11713358 Chimeric polypeptide assembly and methods of making and using the same

‌

US Patent 11744893 Constrained conditionally activated binding proteins

‌

US Patent 11744892 Constrained conditionally activated binding proteins

‌

US Patent 11753466 Anti-CD166 antibodies, activatable anti-CD166 antibodies, and methods of use thereof

...

Patent Primary Examiner

‌

Phuong Huynh

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8513390 Modified antibody compositions, methods of making and using thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API